Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET

Company Participants

Matt Roache - Director of Investor Relations

Tom McCourt - Chief Executive Officer

Mike Shetzline - Chief Medical Officer

Sravan Emany - Chief Financial Officer

Conference Call Participants

Jason Butler - JMP Securities

David Amsellem - Piper Sandler

Boris Peaker - TD Cowen

Tim Chiang - Capital One

Operator

Thank you for standing by. My name is Aaron, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals Q3 2023 Investor Update Conference Call. [Operator Instructions]

I would now like to turn our call over to Matt Roche, Director of Investor Relations. Matt, please go ahead.

Matt Roache

Thank you, Aaron. Good morning and thanks for joining us for our third quarter 2023 investor update. Our press release issued this morning found on our website. Today's call and accompanying slides include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available on the current safe harbor statement slide as well as under the heading Risk Factors in our annual report on Form 10-K for the year ended December 31, 2022 and in our quarterly report on Form 10-Q for the second quarter ended June 30, 2023 in our subsequent SEC filings.

All forward-looking statements speak as the date of this presentation. We undertake no obligation to update such statements. Also included are non-GAAP financial measures, which should be considered only as a subsequent to and not a substitute for or superior to GAAP measures. To the extent applicable, please refer to the tables at the end of our press release for reconciliations of these measures to the most directly comparable GAAP measures.

During today's call, Tom McCourt, our Chief Executive Officer will begin with a brief overview. Mike Shetzline our Chief Medical Officer will discuss our pipeline; and Sravan Emany our Chief Financial Officer provide a commercial update and review our financial results and guidance. Today's webcast includes slides, so for those of you dialing in please go to the Events section of our website to access the accompanying slides separately.

With that, I'll turn the call over to Tom.

Tom McCourt

Thanks, Matt, and good morning, everyone, and thanks for joining us today. As we approach the end of the year, and look back on the progress we've made across our strategic priorities, we are pleased with the strides taken towards realizing our vision to become the leading GI health care company in the industry.